Form 8.3 - Science in Sport plc

RNS Number : 9929C

Science in Sport PLC

14 October 2022

 

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1.  KEY INFORMATION

(a) Full name of discloser:	Science in Sport plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):   The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:   Use a separate form for each offeror/offeree	Science in Sport plc
(d) Is the discloser the offeror or the offeree?	OFFEREE
(e) Date position held:   The latest practicable date prior to the disclosure	13 October 2022
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?   If it is a cash offer or possible cash offer, state "N/A"	No

2.  POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)  Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security:
	Interests		Short positions
	Number	%	Number	%
(1) Relevant securities owned and/or controlled:
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b)  Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3.  POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Name of director Number of Science in Sport plc ordinary shares held Percentage of total issued share capital John Clarke 313,635 0.23 Stephen Moon 924,537 0.66 Daniel Lampard (incoming CFO) nil nil Tim Wright 156,823 0.11 Roger Mather 106,790 0.08 Rights to subscribe for new securities Stephen Moon and Daniel Lampard agreed to subscribe for 221,574 and 33,333 shares respectively at a price of 15p in Science in Sport Plc on 30 September 2022 Options held by directors of Science in Sport plc in Science in Sport plc ordinary shares Name of director Grant date Number of Science in Sport plc ordinary shares in which options granted Exercise price Earliest exercise date Expiry Date John Clarke 22 March 2016 221,360 nil 22 March 2016 21 March 2026 John Clarke 26 Sept 2016 327,273 nil 22 March 2019 25 Sept 2026 Stephen Moon 22 July 2014 328,125 nil 22 July 2014 21 July 2024 Stephen Moon 26 March 2015 267,206 nil 25 March 2015 25 March 2025 Stephen Moon 22 March 2016 1,089,675 nil 22 March 2016 21 March 2026 Stephen Moon 26 Sept 2016 1,460,356 nil 22 March 2019 25 Sept 2026 Stephen Moon 22 March 2017 623,721 nil 22 March 2017 21 March 2027 Stephen Moon 22 March 2017 460,164 nil 22 March 2018 21 March 2027 Stephen Moon 21 March 2018 81,806 nil 21 March 2018 20 March 2027 Stephen Moon 20 March 2019 780,769 nil 20 March 2019 20 March 2029 Stephen Moon 1 October 2020 1,108,070 nil 1 October 2020 1 October 2030 Stephen Moon 1 October 2020 1,555,612 nil 1 April 2022 1 April 2032

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4.  OTHER INFORMATION

(a)  Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b)  Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"

None

(c)  Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions)	NO
Supplemental Form 8 (SBL)	NO

Date of disclosure:	13 October 2022
Contact name:	Stephen Moon
Telephone number:	02074003700

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on [phone].

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

 

END

 

 

RETFFLFLLEESEES